Revolution Medicines, Inc. (RVMD)
189.26
-4.26
(-2.20%)
USD |
NASDAQ |
Oct 15, 16:00
190.00
+0.74
(+0.39%)
After-Hours: 20:00
Revolution Medicines Cash from Operations (TTM) : -1.223B for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.223B |
| March 31, 2026 | -1.057B |
| December 31, 2025 | -897.74M |
| September 30, 2025 | -761.79M |
| June 30, 2025 | -684.90M |
| March 31, 2025 | -591.31M |
| December 31, 2024 | -557.44M |
| September 30, 2024 | -539.71M |
| June 30, 2024 | -509.79M |
| March 31, 2024 | -448.74M |
| December 31, 2023 | -350.57M |
| September 30, 2023 | -291.80M |
| Date | Value |
|---|---|
| June 30, 2023 | -243.04M |
| March 31, 2023 | -231.63M |
| December 31, 2022 | -224.40M |
| September 30, 2022 | -201.88M |
| June 30, 2022 | -186.73M |
| March 31, 2022 | -165.09M |
| December 31, 2021 | -147.18M |
| September 30, 2021 | -132.95M |
| June 30, 2021 | -123.38M |
| March 31, 2021 | -109.29M |
| December 31, 2020 | -100.06M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Intellia Therapeutics, Inc. | -346.64M |
| Twist Bioscience Corp. | -53.07M |
| Beam Therapeutics, Inc. | -359.38M |